TRZ attenuates the generation of advanced glycation end-products by ameliorating chronic hyperglycemia in patients with chronic kidney disease (Caruso and Giorgino 2024)
Market Segmentation Drug Class Insights (Revenue, USD Bn, 2021 - 2033) Exenatide Liraglutide Dulaglutide Lixisenatide Albiglutide Semaglutide Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) Parenteral Oral Application Insights (Revenue, USD Bn, 2021 - 2033) Type 2 Diabetes Mellitus Obesity Liver Cirrhosis Non-alcoholic Steatohepatitis Others Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) Hospital Pharmacies Retail Pharmacies Online Pharmacies Regional Insights (Revenue, USD Bn, 2021 - 2033) North America U.S
Effect of the GLP-1 agonist lixisenatide on the pharmacokinetics of warfarin
It provided the scale and methodological rigor that earlier studies lacked
Tirzepatide is only recommended in patients who have a body mass index (BMI) of 35 kg/m2 or more and specific psychological or other medical problems associated with obesity, or who have a BMI of less than 35 kg/m2 but in whom insulin therapy would have significant occupational implications, or weight loss would benefit other significant obesity-related complications
Conversely, GH-deficient animal models, like Ames and Snell dwarf mice, exhibit longer lifespans and delayed ageing, underscoring the benefits of decreased GH/IGF-1 signalling for pro-longevity (Sun et al